Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk

Breast Cancer Research and Treatment

Volumn 139, Issue 1, 2013, Pages 267-275

  Yang, Ziang ^a   Shen, Juping ^a,b   Cao, Zhigang ^a,b   Wang, Biyun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

6q25.1; Breast cancer and meta analysis; Polymorphism; rs2046210; Variant

Indexed keywords

ADENINE; ESTROGEN RECEPTOR ALPHA;

AFRICAN; ALLELE; ARTICLE; ASIAN; BREAST CANCER; C6ORF97 GENE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CHROMOSOME 6Q; CONTROLLED STUDY; ESTROGEN RECEPTOR 1 GENE; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ETHNICITY; EUROPEAN; GENE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; REPLICATION STUDY; RISK ASSESSMENT; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84877580070     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2494-1     Document Type: Article

References (40)

1. Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33(Suppl):238-244
2. Nathanson KL, Wooster R, Weber BL (2001) Breast cancer genetics: what we know and what we need. Nat Med 7(5):552-556
3. Peto J, Collins N, Barfoot R, Seal S, Warren W et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91(11):943-949
4. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4(11):850-860
5. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK et al (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41(5):585-590
6. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R et al (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42(10):885-892
7. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087-1093
8. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ et al (2011) Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst 103(5):425-435
9. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7):870-874
10. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J et al (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39(7):865-869
11. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA et al (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40(6):703-706
12. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S et al (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41(5):579-584
13. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A et al (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42(6):504-507
14. Zheng W, Long J, Gao YT, Li C, Zheng Y et al (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41(3):324-328
15. Figtree GA, Noonan JE, Bhindi R, Collins P (2009) Estrogen receptor polymorphisms: significance to human physiology, disease and therapy. Recent Pat DNA Gene Seq 3(3):164-171
16. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S et al (2009) Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 18(6):1131-1139
17. Li N, Dong J, Hu Z, Shen H, Dai M (2010) Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121(1):177-184
18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-188
19. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19(4):251-253
20. Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L et al (2011) Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 20(16):3304-3321
21. Cai Q, Wen W, Qu S, Li G, Egan KM et al (2011) Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of Chinese, Japanese, and European ancestry. Cancer Res 71(4):1344-1355
22. Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC et al (2011) Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst 103(16):1252-1263
23. Chan M, Ji SM, Liaw CS, Yap YS, Law HY et al (2012) Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. Breast Cancer Res Treat 136(1):209-220
24. Han W, Woo JH, Yu JH, Lee MJ, Moon HG et al (2011) Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol Biomarkers Prev 20(5):793-798
25. Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC et al (2012) Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS ONE 7(8):e42380
26. Jiang Y, Han J, Liu J, Zhang G, Wang L et al (2011) Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province. Breast Cancer Res Treat 128(1):251-257
27. Kim HC, Lee JY, Sung H, Choi JY, Park SK et al (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 14(2):R56
28. Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D et al (2011) Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res 13(6):R110
29. Ruiz-Narvaez EA, Rosenberg L, Yao S, Rotimi CN, Cupples AL et al (2012) Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women. Carcinogenesis 34(2):287-291
30. Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G et al (2010) Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 6(7):e1001029
31. Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T et al (2011) Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 71(19):6240-6249
32. Sueta A, Ito H, Kawase T, Hirose K, Hosono S et al (2012) A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat 132(2):711-721
33. Cancer CGoHFiB (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360(9328):187-195
34. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
35. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J et al (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4(4):e1000054
36. Long J, Shu XO, Cai Q, Gao YT, Zheng Y et al (2010) Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 19(9):2357-2365
37. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606-616
38. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA et al (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82(4):937-948
39. Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H et al (2009) Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 18(22):4442-4456
40. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S et al (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70(23):9742-9754